Neurocrine Biosciences, Inc. (FRA:NB3)

Neurocrine Biosciences Revenue

Neurocrine Biosciences had revenue of $794.90M USD in the quarter ending September 30, 2025, with 27.78% growth. This brings the company's revenue in the last twelve months to $2.68B, up 19.61% year-over-year. In the year 2024, Neurocrine Biosciences had annual revenue of $2.36B with 24.81% growth.

• Revenue (ttm): $2.68B
• Revenue Growth: +19.61%
• P/S Ratio: 5.66
• Revenue / Employee: $1.49M
• Employees: 1,800
• Market Cap: 12.94B EUR

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	2.36B	468.20M	24.81%
Dec 31, 2023	1.89B	398.40M	26.76%
Dec 31, 2022	1.49B	355.20M	31.34%
Dec 31, 2021	1.13B	87.60M	8.38%
Dec 31, 2020	1.05B	257.80M	32.71%
Dec 31, 2019	788.10M	336.90M	74.67%
Dec 31, 2018	451.20M	289.57M	179.16%
Dec 31, 2017	161.63M	146.63M	977.51%
Dec 31, 2016	15.00M	-4.77M	-24.12%
Dec 31, 2015	19.77M	-	-
Dec 31, 2014	-	-	-
Dec 31, 2013	2.92M	-50.22M	-94.51%
Dec 31, 2012	53.14M	-24.27M	-31.36%
Dec 31, 2011	77.41M	43.91M	131.08%
Dec 31, 2010	33.50M	30.55M	1,034.47%
Dec 31, 2009	2.95M	-1.02M	-25.71%
Dec 31, 2008	3.98M	2.75M	224.75%
Dec 31, 2007	1.22M	-38.01M	-96.88%
Dec 31, 2006	39.23M	-84.66M	-68.33%
Dec 31, 2005	123.89M	-	-